Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.32 |
| ▸ | GRM3 | Q14832 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | CHRNA1 | P02708 | 1/20 | 0.30 |
| ▸ | CHRNG | P07510 | 1/20 | 0.30 |
| ▸ | ITGA5 | P08648 | 1/20 | 0.30 |
| ▸ | CHRNB1 | P11230 | 1/20 | 0.30 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.30 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.30 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.30 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.30 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.30 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.30 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.30 |
| ▸ | CHRND | Q07001 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3361604 | 0.93 | TSHR (0.36) | TSHRCHRNA1CHRNGITGA5CHRNB1 | |
| SCHEMBL15645296 | 0.91 | POLB (0.42) | POLBTDP1CTDSP1KMT2ATSHR | |
| SCHEMBL17332189 | 0.81 | POLB (0.43) | POLBTDP1CTDSP1GRM2GRM3 | |
| SCHEMBL3278963 | 0.80 | POLB (0.55) | POLBTDP1CTDSP1GRM2GRM3 | |
| SCHEMBL27746022 | 0.79 | TSHR (0.37) | POLBTDP1CTDSP1KMT2AGRM2 | |
| SCHEMBL29259887 | 0.76 | TSHR (0.42) | POLBTDP1CTDSP1TSHRCHRNA1 | |
| SCHEMBL1194506 | 0.72 | POLB (0.46) | POLBTDP1CTDSP1TSHRCHRNA1 | |
| SCHEMBL31276060 | 0.72 | SMN1; SMN2 (0.35) | CHRNA1CHRNGITGA5CHRNB1CHRNB2 | |
| SCHEMBL6737476 | 0.72 | POLB (0.50) | POLBTDP1CTDSP1GRM2GRM3 | |
| SCHEMBL19285910 | 0.72 | POLB (0.50) | POLBTDP1CTDSP1GRM2GRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090069503-A1 | SULFUR-CONTAINING CYCLIC OLEFIN RESIN AND ITS PRODUCTION METHOD | TOSOH CORPORATION (JP) | 2009-03-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090069503-A1 | SULFUR-CONTAINING CYCLIC OLEFIN RESIN AND ITS PRODUCTION METHOD | ACSL3, ACSL1, RPS27L | POLB 3388/4885TDP1 4525/4885CTDSP1 1819/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.